|
Gain expert insights into addressing some of the biggest challenges in drug development |
|
Discussions around the increasing cost of drug development has dominated industry forums for many years. However, it is only in the last few years that the industry has started to reflect on whether the reaction to this challenge has actually increased the complexity (and consequently the cost) of drug development. |
|
ICON hosted a panel session with industry experts to gather their insights on addressing the challenges of increasing complexity and declining ROI in drug development. These topics included: |
|
| – |
|
Leveraging technology to improve decision-making and reduce costs |
| |
| – |
|
Engaging the investigator for better outcomes |
| |
| – |
|
Democratising trials for more accurate results |
| |
| – |
|
Patients as partners, not subjects, in clinical research |
| |
|
